Wang Ronghua 4
4 · Biostar Pharmaceuticals, Inc. · Filed Jun 2, 2011
Insider Transaction Report
Form 4
Wang Ronghua
DirectorChairman, CEO10% Owner
Transactions
- Purchase
Common Stock
2011-06-01$1.37/sh+200$274→ 8,977,273 total - Purchase
Common Stock
2011-06-01$1.31/sh+1,811$2,372→ 8,969,873 total - Purchase
Common Stock
2011-06-01$1.32/sh+2,500$3,300→ 8,972,373 total - Purchase
Common Stock
2011-06-01$1.33/sh+1,700$2,261→ 8,974,073 total - Purchase
Common Stock
2011-06-01$1.36/sh+1,300$1,768→ 8,977,073 total - Purchase
Common Stock
2011-06-01$1.30/sh+1.089$1→ 8,968,062 total - Purchase
Common Stock
2011-06-01$1.38/sh+100$138→ 8,977,373 total
Footnotes (1)
- [F1]Purchase made pursuant to the stock repurchase plan of the Reporting Person as previously approved by the Board of Directors.